1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Oriola Oyj
  6. Summary
    OKDBV   FI0009014351

ORIOLA OYJ

(OKDBV)
  Report
Delayed Quote. Delayed Nasdaq Helsinki - 05/27 11:29:47 am
2.115 EUR   +1.44%
05/27Finnish Healthcare Company Oriola's CFO Quits
MT
05/27CHANGE IN ORIOLA MANAGEMENT TEAM : Sari Pohjonen to leave Oriola
AQ
05/27Oriola Corporation Announces Resignation of Sari Pohjonen as CFO
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Helsinki
05/20/2022 05/23/2022 05/24/2022 05/25/2022 05/27/2022 Date
2.115(c) 2.11(c) 2.14(c) 2.085(c) 2.115(c) Last
85 456 95 632 139 830 142 686 68 312 Volume
+1.68% -0.24% +1.42% -2.57% +1.44% Change
More quotes
Estimated financial data (e)
Sales 2022 1 730 M 1 853 M 1 853 M
Net income 2022 38,6 M 41,3 M 41,3 M
Net Debt 2022 112 M 119 M 119 M
P/E ratio 2022 10,0x
Yield 2022 2,68%
Sales 2023 1 889 M 2 024 M 2 024 M
Net income 2023 32,5 M 34,8 M 34,8 M
Net Debt 2023 69,8 M 74,8 M 74,8 M
P/E ratio 2023 11,9x
Yield 2023 3,31%
Capitalization 382 M 410 M 410 M
EV / Sales 2022 0,29x
EV / Sales 2023 0,24x
Nbr of Employees 1 031
Free-Float 69,6%
More Financials
Company
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides... 
Sector
Drug Retailers
Calendar
07/22Earnings Release
More about the company
Ratings of Oriola Oyj
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about ORIOLA OYJ
05/27Finnish Healthcare Company Oriola's CFO Quits
MT
05/27CHANGE IN ORIOLA MANAGEMENT TEAM : Sari Pohjonen to leave Oriola
AQ
05/27Oriola Corporation Announces Resignation of Sari Pohjonen as CFO
CI
05/16Oriola and Euroapotheca announce prospective CEO and Chairman of the Board for the plan..
AQ
05/16Changes in Oriola Management Team
AQ
05/10Finland's Oriola Names New CEO
MT
05/10Katarina Gabrielson appointed as CEO of Oriola
AQ
05/10Oriola Corporation Appoints Katarina Gabrielson as CEO Starting from 10 May 2022
CI
05/04Oriola Corporation - Managers' Transactions
AQ
04/28TRANSCRIPT : Oriola Oyj, Q1 2022 Earnings Call, Apr 28, 2022
CI
04/28Oriola Corporation's Interim report 1 January-31 March 2022
AQ
04/28Oriola Oyj Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/26Oriola's restated financial information for 2021 according to the new segment structure
AQ
04/21Oriola Corporation will publish its Interim report 1 January-31 March 2022 on Thursday,..
AQ
03/31ORIOLA CORPORATION : Flagging notification in accordance with the Finnish Securities Marke..
AQ
More news
News in other languages on ORIOLA OYJ
05/27Le directeur financier de la société finlandaise de soins de santé Oriola démissionne
05/10La société finlandaise Oriola nomme un nouveau PDG
05/10Oriola Corporation nomme Katarina Gabrielson au poste de PDG à partir du 10 mai 2022
04/28Oriola Oyj annonce ses résultats financiers pour le premier trimestre clos le 31 mars 2..
03/15Oriola Oyj approuve la nomination de Nina Mähönen comme nouveau membre du conseil d'adm..
More news
Chart ORIOLA OYJ
Duration : Period :
Oriola Oyj Technical Analysis Chart | OKDBV | FI0009014351 | MarketScreener
Technical analysis trends ORIOLA OYJ
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 2,12 €
Average target price 2,57 €
Spread / Average Target 21,4%
EPS Revisions
Managers and Directors
Katarina Gabrielson Vice President-Oriola Sweden
Sari Pohjonen Chief Financial Officer
Panu Henrik Routila Chairman
Charlotta Nystr÷m Chief Information Officer
Anne Kariniemi Vice President-Operations
Sector and Competitors